Lorrain Daniel S. Insider Trading Activity
Lorrain Daniel S. has been net-selling over the last 12 months with 0 purchases and 15 sales across 1 company.
CTNM is the most-traded position with 15 trades. The largest single transaction was a sale of CTNM for $69K on Feb 24, 2026.
Performance Scorecard
Forward stock performance after each transaction by Lorrain Daniel S.. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | +1.8% | 69% | 13 |
| 90 days | — | +1.9% | 64% | 11 |
| 120 days | — | +3.8% | 60% | 10 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersCTNM · Contineum Therapeutics, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Lorrain Daniel S. bought and sold CTNM.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jul 9, 2026 | CTNM | Sell | 25 | $16.00 | $400 | −0.0% | Chief Scientific Officer | |
Jul 8, 2026 | CTNM | Sell | 1,015 | $16.00 | $16K | −0.7% | Chief Scientific Officer | |
May 1, 2026 | CTNM | Sell | 3,870 | $13.06 | $51K | −2.6% | Chief Scientific Officer | |
May 1, 2026 | CTNM | Sell | 300 | $13.84 | $4K | −0.2% | Chief Scientific Officer | |
Apr 6, 2026 | CTNM | Sell | 4,170 | $13.43 | $56K | −2.7% | Chief Scientific Officer | |
Mar 2, 2026 | CTNM | Sell | 4,170 | $15.01 | $63K | −2.7% | Chief Scientific Officer | |
Feb 25, 2026 | CTNM | Sell | 3,824 | $16.01 | $61K | −2.4% | Chief Scientific Officer | |
Feb 24, 2026 | CTNM | Sell | 4,300 | $16.03 | $69K | −2.7% | Chief Scientific Officer | |
Feb 19, 2026 | CTNM | Sell | 100 | $16.00 | $2K | −0.1% | Chief Scientific Officer | |
Feb 11, 2026 | CTNM | Sell | 400 | $16.00 | $6K | −0.3% | Chief Scientific Officer | |
Feb 3, 2026 | CTNM | Sell | 1,170 | $15.25 | $18K | −0.7% | Chief Scientific Officer | |
Feb 3, 2026 | CTNM | Sell | 3,000 | $14.82 | $44K | −1.9% | Chief Scientific Officer | |
Jan 5, 2026 | CTNM | Sell | 500 | $11.13 | $6K | −0.3% | Chief Scientific Officer | |
Jan 5, 2026 | CTNM | Sell | 3,670 | $10.35 | $38K | −2.2% | Chief Scientific Officer | |
Dec 23, 2025 Filed 5d late | CTNM | Sell | 4,170 | $12.23 | $51K | −2.5% | Chief Scientific Officer |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 15 | $485K |
Other insiders at Contineum Therapeutics, Inc.
2 other tracked filers at CTNM.